The goal of this clinical trial is to assess whether the Uriclarity Program is effective in reducing the perception of insufficient milk supply (PIM) in postpartum women. The study also aims to evaluate the feasibility of implementing this program as a lactation support strategy. The main research questions are: Does the Uriclarity Program reduce the perception of insufficient milk supply among postpartum women? How does the program impact breastfeeding confidence and adherence to exclusive breastfeeding? Researchers will compare the Uriclarity Program to standard postpartum lactation counseling to determine its effectiveness. Participants will: Receive either the Uriclarity Program intervention or standard lactation counseling within 24-48 hours postpartum. Be evaluated on days 1, 3, 7, and 14 postpartum using the PIM questionnaire to assess changes in perception. Engage in follow-up via WhatsApp support groups (for the intervention group). This randomized controlled trial will provide evidence on whether the Uriclarity Program can effectively reduce maternal concerns about milk supply and support exclusive breastfeeding.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Reduction in Perceived Insufficient Milk Supply (PIM) Score
Timeframe: Baseline (Day 1), Day 3, Day 7, and Day 14 postpartum